Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Primary completion date changed from estimate of Dec 31, 2026 to May 30, 2026
  2. Enrollment closed, study ongoing Show 4 more changesShow less
    • Final enrollment: 20 participants (planned 30)
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
    • Eligibility criteria expanded, about 4 words
  3. Primary and study completion pushed from Apr 30, 2026 to Dec 31, 2026v7
  4. Primary and study completion dates: Apr 30, 2025 to Apr 30, 2026v6
  5. Primary and study completion dates: Apr 30, 2024 to Apr 30, 2025v5
Show 3 earlier versionsHide 3 earlier versions
  1. 2 versions Re-verified since Feb 8, 2024, no change to tracked fieldsv3-v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 31, 2022 to Nov 29, 2022
    • Site details revised
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial studies the effectiveness of a newly developed survivorship mobile application (app) designed for survivors, or their caregivers, of childhood cancer to help them better navigate long-term follow-up care. The survivorship app provides survivors access to their treatment history and follow-up recommendations, improves knowledge of their diagnosis, treatment, risks, and recommended follow-up care by using a message notification. The ability to quickly connect and establish care planning may enhance adherence to recommended follow-up.
Trial Details
NCT Number NCT05641961
Lead Sponsor University of California, San Francisco
Collaborators: Swim Across America
Conditions
(from sponsor)		 Childhood Cancer, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Related terms Hematologic Neoplasms, Neoplasms
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov